http://orcid.org/0000-0003-0199-5786
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ola Dale. (2022) Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 203-217.
Read now
Read now
Eleanor Rochester & Melissa Graboyes. (2022) Experiences of people who use drugs with naloxone administration: a qualitative study. Drugs: Education, Prevention and Policy 29:1, pages 54-61.
Read now
Read now
Articles from other publishers (18)
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta & Jakub Wojcieszak. (2023) Non-fentanyl new synthetic opioids – An update. Forensic Science International 349, pages 111775.
Crossref
Crossref
Christine Ramdin, Kira Chandran, Lewis Nelson & Maryann Mazer-Amirshahi. (2023) Trends in naloxone prescribed at emergency department discharge: A national analysis (2012–2019). The American Journal of Emergency Medicine 65, pages 162-167.
Crossref
Crossref
Harrison J. Elder, Neil B. Varshneya, D. Matthew Walentiny & Patrick M. Beardsley. (2023) Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner. Drug and Alcohol Dependence 243, pages 109740.
Crossref
Crossref
James A. Swartz, Qiao Lin & Yerim Kim. (2022) A measurement invariance analysis of selected Opioid Overdose Knowledge Scale (OOKS) items among bystanders and first responders. PLOS ONE 17:10, pages e0271418.
Crossref
Crossref
Savitha Racha, Megan Buresh & Michael Fingerhood. (2022) Pharmacotherapy of Opioid Use Disorder—Update and Current Challenges. Psychiatric Clinics of North America 45:3, pages 335-346.
Crossref
Crossref
Stevie C. Britch & Sharon L. Walsh. (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239:7, pages 2063-2081.
Crossref
Crossref
Arne Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne‐Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo & Ola Dale. (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial. Addiction 117:6, pages 1658-1667.
Crossref
Crossref
Philipp Schmidt, Christine Kolb, Andreas Reiser, Markus Philipp, Hans-Christian Müller & Konstantin Karaghiosoff. (2022) Isolation, Identification and Structural Verification of a Methylene-Bridged Naloxone “Dimer” Formed by Formaldehyde. Journal of Pharmaceutical Sciences 111:6, pages 1682-1689.
Crossref
Crossref
Kelly Quinn, Sagar Kumar, Calli T. Hunter, Julie O’Donnell & Nicole L. Davis. (2022) Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019. Drug and Alcohol Dependence 235, pages 109467.
Crossref
Crossref
Judith Rodriguez Salas, Alex J Krotulski, Reta Newman, Jon R Thogmartin, Amanda L A Mohr & Barry K Logan. (2022)
Concentrations of
para
-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations
. Journal of Analytical Toxicology 46:4, pages 358-373.
Crossref
Crossref
Joseph V. PergolizziJrJr, Albert Dahan, Jo Ann LeQuang & Robert B. Raffa. (2021) Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1501-1504.
Crossref
Crossref
Robert A. Lavin, Che Liu, Larry Yuspeh, Nimisha Kalia, Nina Leung, Nicholas F. Tsourmas, Leila Williams, Dan L. Hunt, Edward J. Bernacki & Xuguang (Grant) Tao. (2021) Trends in the Utilization and Dose of Gabapentinoids in Combination With Opioids in an Injured Worker Population Between 2008 and 2018. Journal of Occupational & Environmental Medicine 63:10, pages e694-e700.
Crossref
Crossref
Elizabeth N. Kinnard, Ricky N. Bluthenthal, Alex H. Kral, Lynn D. Wenger & Barrot H. Lambdin. (2021) The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA. Drug and Alcohol Dependence 225, pages 108759.
Crossref
Crossref
Nicholas J Connors, Maryann Mazer-Amirshahi, Sergey Motov & Hong K Kim. (2021) Relative addictive potential of opioid analgesic agents. Pain Management 11:2, pages 201-215.
Crossref
Crossref
Daniel R. Harris, Christian Eisinger, Yanning Wang & Chris Delcher. (2020) Challenges and Barriers in Applying Natural Language Processing to Medical Examiner Notes from Fatal Opioid Poisoning Cases. Challenges and Barriers in Applying Natural Language Processing to Medical Examiner Notes from Fatal Opioid Poisoning Cases.
G. Franklin EdwardsIIIIII, Cassandra Mierisch, Brock Mutcheson, Kimberly Horn & Sarah Henrickson Parker. (2020) A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs. Preventive Medicine Reports 20, pages 101232.
Crossref
Crossref
Lala Tanmoy Das & Eric Kutscher. (2020) Stimulant Use Disorders in the United States—Is Another Epidemic on The Horizon?. JAMA Health Forum 1:12, pages e201486.
Crossref
Crossref
Ying Han, Wei Yan, Yongbo Zheng, Muhammad Zahid Khan, Kai Yuan & Lin Lu. (2019) The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Translational Psychiatry 9:1.
Crossref
Crossref